NADclinic to Lead Longevity’s Operational Shift at 2026 Show: From Clinics to Systems

As the longevity industry pivots from theory to execution, NADclinic’s 2026 showcase at The Longevity Show signals a new era of operational rigor in premium wellness.

The company has been named an Innovator Partner for the event, which will take place in London on 26–27 June 2026.

NADclinic will host a panel on *The Longevity Clinic of 2035*, a roundtable on operational challenges, and an immersive Performance Hub activation.

The event aligns with the company’s mission to transition the sector from conceptual innovation to scalable, standardized clinical infrastructure.

Iain De Havilland, NADclinic CEO, said:

"Longevity is entering its execution phase... we want NADclinic to be."

Phil Newman, cofounder of The Longevity Show, added:

"NAD+ supplementation is such a cornerstone to people’s healthspan... we’re excited for their team to share their knowledge."

NADclinic operates in 40+ countries, offering NAD+ injectables, diagnostics, and nutraceuticals through a "plug-and-play" clinic model.

Its ecosystem integrates NAD+ with peptides, exosomes, and vitamins to create "menu-driven" clinic offerings.

The Longevity Show positions itself as a platform to connect innovation with delivery, emphasizing scalability, standardization, and operational execution over abstract concepts.

⚠️ LEGAL DISCLAIMER: It is for informational purposes only. It never substitutes for professional medical advice, diagnosis, or treatment. Always consult your doctor regarding any questions about your health.